The FDA has begun implementing an artificial intelligence tool across the entire agency earlier than originally planned. This move marks a significant step in the agency’s adoption of advanced technology to transform healthcare and life sciences. The rollout is expected to impact various sectors including biotech, pharma, and public health, advancing regulatory efficiency and decision-making processes.
Related articles:
Artificial Intelligence in Health IT
AI Tools in Hospitals and Implementation Barriers
FDA’s Approach to Regulating Medical AI
